ServiceNow, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ServiceNow, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.93B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $1.39B | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $1.01B | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $682.56M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $424.65M | Feb 25, 2016 |
| FY2014 | Dec 31, 2012 | $243.71M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $73.38M | Feb 28, 2014 |
| FY2013 | Jun 30, 2011 | $92.64M | Feb 28, 2014 |
| FY2013 | Dec 31, 2010 | $37.94M | Feb 28, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.28B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $10.98B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $8.97B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $7.25B | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $5.90B | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $4.52B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $3.46B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $2.61B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $1.92B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.39B | Feb 27, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.93B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $1.39B | Feb 28, 2018 |
| FY2017 | Dec 31, 2015 | $1.01B | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $682.56M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $424.65M | Feb 25, 2016 |
| FY2014 | Dec 31, 2012 | $243.71M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $73.38M | Feb 28, 2014 |
| FY2013 | Jun 30, 2011 | $92.64M | Feb 28, 2014 |
| FY2013 | Dec 31, 2010 | $37.94M | Feb 28, 2014 |
| FY2012 | Jun 30, 2010 | $43.33M | Mar 8, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.30B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $8.70B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $7.05B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $5.67B | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $4.54B | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $3.53B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $2.66B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $1.99B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $1.42B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $991.99M | Feb 27, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $1.43B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $1.73B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $325.00M | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $230.00M | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $119.00M | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $626.70M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | ($26.70M) | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | ($116.85M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($414.25M) | Feb 27, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.82B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $1.36B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $762.00M | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $355.00M | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $257.00M | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $199.00M | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $42.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | ($42.43M) | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | ($64.40M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($382.17M) | Feb 27, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.96B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $2.54B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $2.12B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $1.77B | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $1.40B | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $1.02B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $749.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $529.50M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $377.52M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $285.24M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.44B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $4.27B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $3.40B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $2.72B | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $2.19B | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $1.79B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $1.24B | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $811.09M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $642.94M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $159.08M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $868.00M | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $852.00M | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $694.00M | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $550.00M | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $392.00M | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $419.00M | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $265.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $224.46M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $150.51M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $105.56M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.04B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $20.38B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $17.39B | Jan 30, 2025 |
| FY2023 | Dec 31, 2022 | $13.30B | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | $10.80B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.72B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $6.02B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $3.88B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $3.55B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.03B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.07B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $10.77B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $9.76B | Jan 30, 2025 |
| FY2023 | Dec 31, 2022 | $8.27B | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | $7.10B | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | $5.88B | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | $3.89B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $2.77B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $2.77B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.65B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.96B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $9.61B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $7.63B | Jan 29, 2026 |
| FY2025 | Dec 31, 2022 | $5.03B | Jan 29, 2026 |
| FY2024 | Dec 31, 2021 | $3.70B | Jan 30, 2025 |
| FY2023 | Dec 31, 2020 | $2.83B | Jan 25, 2024 |
| FY2022 | Dec 31, 2019 | $2.13B | Jan 31, 2023 |
| FY2021 | Dec 31, 2018 | $1.11B | Feb 3, 2022 |
| FY2020 | Dec 31, 2017 | $778.74M | Feb 12, 2021 |
| FY2019 | Dec 31, 2016 | $541.09M | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.58B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $1.27B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $1.23B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $824.00M | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $777.00M | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $241.00M | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $157.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $148.85M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $128.73M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $82.53M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.24B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $3.49B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | $2.07B | Jan 30, 2025 |
| FY2023 | Dec 31, 2022 | $338.00M | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | ($4.00M) | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | ($234.00M) | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | ($352.24M) | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | ($978.78M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($958.56M) | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | ($997.39M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.73B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | $2.30B | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | $1.90B | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | $1.47B | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | $1.73B | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | $1.68B | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | $776.00M | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | $566.20M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $726.50M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $401.24M | Feb 27, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 20, 2020 |
| FY2013 | Dec 31, 2013 | 0 | Feb 28, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Jan 29, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Jan 29, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Jan 30, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Jan 31, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 3, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 20, 2020 |
| FY2013 | Dec 31, 2013 | 0 | Feb 28, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.05B | Jan 29, 2026 |
| FY2025 | Dec 31, 2024 | 1.03B | Jan 29, 2026 |
| FY2024 | Dec 31, 2023 | 204.72M | Jan 30, 2025 |
| FY2023 | Dec 31, 2022 | 202.88M | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | 199.61M | Jan 31, 2023 |
| FY2021 | Dec 31, 2020 | 195.85M | Feb 3, 2022 |
| FY2020 | Dec 31, 2019 | 189.46M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | 180.18M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 174.28M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 167.43M | Feb 28, 2018 |